Industry: Food & Beverages
Published Date: 2026-05-31
Pages: 173 Pages
Report ld: 6721988
Request Sample
Customized Report
Microalgae DHA Market Size(US$)

CAGR 2026-2032
12.7%
Market Size,2032
USD 1,608
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Microalgae DHA market is projected to grow from US$ 676 million in 2025 to US$ 1608 million by 2032, at a CAGR of 12.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
In 2024, global Microalgae DHA production reached approximately 14,874.9 MT, with an average global market price of around US$45.43 per kg.
Microalgae DHA refers to docosahexaenoic acid (DHA) extracted from microalgae, a polyunsaturated omega-3 fatty acid. Compared to fish oil-derived DHA, microalgae DHA is plant-based, free from marine contaminants, and suitable for vegetarians and pregnant women. It is widely used in infant formula, dietary supplements, functional foods, and pharmaceutical products, supporting brain and eye development, cardiovascular health, and anti-inflammatory functions. As a sustainable, green, and high-value omega-3 source, microalgae DHA has become a key ingredient in the growing global nutraceutical and functional food markets.
Microalgae DHA is a typical high-value nutritional ingredient produced through microbial fermentation. Its production model starts with strain development and metabolic regulation, then extends to fermentation scale-up, oil separation and purification, refining and stabilization, and downstream formulation development. The upstream value chain includes algal strains, carbon and nitrogen sources, fermentation tanks, separation equipment, antioxidants, encapsulation materials, and food-grade packaging. Midstream competitiveness depends on high-yield strains, fermentation productivity, oil recovery rate, DHA concentration, oxidative stability, odor control, regulatory compliance, and the ability to adapt to customer formulas. Downstream markets include infant formula, nutritional supplements, functional foods, health foods, foods for special medical purposes, pet food, and aquaculture feed. Industry gross margins are generally segmented: infant-formula-grade, high-purity, highly stable, microencapsulated, or internationally certified products may typically achieve gross margins of around 35%–55%; standard food-grade or bulk raw-material products are more exposed to pricing pressure and usually fall around 20%–35%. Producers with proprietary strains, scaled fermentation platforms, major brand customers, and multi-market regulatory access tend to maintain more stable profitability. Overall, the industry is evolving from a single nutritional fortification ingredient toward an integrated model combining strain technology, fermentation manufacturing, formulation solutions, and end-use nutrition applications.
Market Development Opportunities & Main Driving Factors
Microalgae DHA, a plant-based and sustainable source of omega-3 fatty acids, continues to attract attention in the global nutrition and health market. According to corporate reports and broker research, the demand for high-quality DHA is rapidly growing in infant formula, prenatal supplements, and cardiovascular health products for older adults, while regulatory support for food safety and nutrient fortification further drives microalgae DHA adoption. The increasing focus on environmental sustainability positions microalgae DHA as a green alternative to fish oil, gaining broader recognition among companies and consumers. In addition, improvements in production processes and fermentation efficiency reduce unit costs, offering companies higher profit potential and greater market penetration opportunities.
Market Challenges, Risks, & Restraints
Despite promising prospects, microalgae DHA faces several challenges. Production costs remain relatively high, requiring stringent control over algal cultivation, extraction and purification technologies, and supply chain management. Broker analyses highlight that intensified market competition, price pressure from new entrants and existing fish oil DHA brands, and high downstream standards for supply stability and certification may constrain expansion. Furthermore, international trade policies, dependence on imported raw materials, and regulatory changes add uncertainty, requiring companies to maintain strategic flexibility and robust risk management.
Downstream Demand Trends
Downstream demand is trending toward premiumization and diversification. Infant formula and maternal nutrition products increasingly require high purity and safety, while functional foods and dietary supplements show stronger consumer preference for sustainable, plant-based sources. As health awareness rises, products targeting cardiovascular, brain, and eye health continue to gain market share. Companies are also emphasizing brand value, supply chain traceability, and innovation capabilities, driving microalgae DHA from a single raw material toward a “product-plus-health solution” business model.
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Microalgae DHA market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Microalgae DHA study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Microalgae DHA: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Microalgae DHA Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 DHA Powder
1.2.3 DHA Oil
1.3 Market Segmentation by DHA Content
1.3.1 Global Microalgae DHA Market Size by DHA Content, 2021 vs 2025 vs 2032
1.3.2 DHA Content: <15%
1.3.3 DHA Content: 15% – 35%
1.3.4 DHA Content: 35% – 50%
1.3.5 DHA Content: >50%
1.4 Market Segmentation by Source
1.4.1 Global Microalgae DHA Market Size by Source, 2021 vs 2025 vs 2032
1.4.2 Schizochytrium
1.4.3 Crypthecodinium Cohnii
1.4.4 Others
1.5 Market Segmentation by Process
1.5.1 Global Microalgae DHA Market Size by Process, 2021 vs 2025 vs 2032
1.5.2 Traditional Solvent Extraction
1.5.3 Enzymatic Extraction
1.5.4 Supercritical CO2 Extraction
1.6 Market Segmentation by Application
1.6.1 Global Microalgae DHA Market Size by Application, 2021 vs 2025 vs 2032
1.6.2 Infant Formula
1.6.3 Nutritional Supplements
1.6.4 Food & Beverage
1.6.5 Others
1.7 Assumptions and Limitations
1.8 Study Objectives
1.9 Years Considered
2 Executive Summary
2.1 Global Microalgae DHA Revenue Estimates and Forecasts (2021-2032)
2.2 Global Microalgae DHA Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Microalgae DHA Sales Estimates and Forecasts (2021-2032)
2.4 Global Microalgae DHA Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Microalgae DHA Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Microalgae DHA Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 DHA Powder: Market Share by Key Manufacturers
3.5.2 DHA Oil: Market Share by Key Manufacturers
3.6 Global Microalgae DHA Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Microalgae DHA Sales Performance by Type
4.1.1 Global Microalgae DHA Sales Volume by Type (2021-2032)
4.1.2 Global Microalgae DHA Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Microalgae DHA Sales Performance by DHA Content
4.2.1 Global Microalgae DHA Sales Volume by DHA Content (2021-2032)
4.2.2 Global Microalgae DHA Revenue by DHA Content (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by DHA Content (2021-2032)
4.3 Global Microalgae DHA Sales Performance by Source
4.3.1 Global Microalgae DHA Sales Volume by Source (2021-2032)
4.3.2 Global Microalgae DHA Revenue by Source (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Source (2021-2032)
4.4 Global Microalgae DHA Sales Performance by Process
4.4.1 Global Microalgae DHA Sales Volume by Process (2021-2032)
4.4.2 Global Microalgae DHA Revenue by Process (2021-2032)
4.4.3 Global Average Selling Price (ASP) Trends by Process (2021-2032)
4.5 Product Technology Differentiation
4.6 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.6.1 High-Growth Niches and Adoption Drivers
4.6.2 Profitability Hotspots and Cost Drivers
4.6.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Microalgae DHA Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Microalgae DHA Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Microalgae DHA Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Microalgae DHA Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Microalgae DHA Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Microalgae DHA Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Microalgae DHA Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Microalgae DHA Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Microalgae DHA Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Microalgae DHA Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Microalgae DHA Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Microalgae DHA Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 DSM-Firmenich
11.1.1 DSM-Firmenich Corporation Information
11.1.2 DSM-Firmenich Business Overview
11.1.3 DSM-Firmenich Microalgae DHA Product Models, Descriptions and Specifications
11.1.4 DSM-Firmenich Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 DSM-Firmenich Microalgae DHA Sales by Product in 2025
11.1.6 DSM-Firmenich Microalgae DHA Sales by Application in 2025
11.1.7 DSM-Firmenich Microalgae DHA Sales by Geographic Area in 2025
11.1.8 DSM-Firmenich Microalgae DHA SWOT Analysis
11.1.9 DSM-Firmenich Recent Developments
11.2 Roquette
11.2.1 Roquette Corporation Information
11.2.2 Roquette Business Overview
11.2.3 Roquette Microalgae DHA Product Models, Descriptions and Specifications
11.2.4 Roquette Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Roquette Microalgae DHA Sales by Product in 2025
11.2.6 Roquette Microalgae DHA Sales by Application in 2025
11.2.7 Roquette Microalgae DHA Sales by Geographic Area in 2025
11.2.8 Roquette Microalgae DHA SWOT Analysis
11.2.9 Roquette Recent Developments
11.3 Corbion
11.3.1 Corbion Corporation Information
11.3.2 Corbion Business Overview
11.3.3 Corbion Microalgae DHA Product Models, Descriptions and Specifications
11.3.4 Corbion Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Corbion Microalgae DHA Sales by Product in 2025
11.3.6 Corbion Microalgae DHA Sales by Application in 2025
11.3.7 Corbion Microalgae DHA Sales by Geographic Area in 2025
11.3.8 Corbion Microalgae DHA SWOT Analysis
11.3.9 Corbion Recent Developments
11.4 Huison
11.4.1 Huison Corporation Information
11.4.2 Huison Business Overview
11.4.3 Huison Microalgae DHA Product Models, Descriptions and Specifications
11.4.4 Huison Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Huison Microalgae DHA Sales by Product in 2025
11.4.6 Huison Microalgae DHA Sales by Application in 2025
11.4.7 Huison Microalgae DHA Sales by Geographic Area in 2025
11.4.8 Huison Microalgae DHA SWOT Analysis
11.4.9 Huison Recent Developments
11.5 Runke
11.5.1 Runke Corporation Information
11.5.2 Runke Business Overview
11.5.3 Runke Microalgae DHA Product Models, Descriptions and Specifications
11.5.4 Runke Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Runke Microalgae DHA Sales by Product in 2025
11.5.6 Runke Microalgae DHA Sales by Application in 2025
11.5.7 Runke Microalgae DHA Sales by Geographic Area in 2025
11.5.8 Runke Microalgae DHA SWOT Analysis
11.5.9 Runke Recent Developments
11.6 ADM
11.6.1 ADM Corporation Information
11.6.2 ADM Business Overview
11.6.3 ADM Microalgae DHA Product Models, Descriptions and Specifications
11.6.4 ADM Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 ADM Recent Developments
11.7 Mara Renewables
11.7.1 Mara Renewables Corporation Information
11.7.2 Mara Renewables Business Overview
11.7.3 Mara Renewables Microalgae DHA Product Models, Descriptions and Specifications
11.7.4 Mara Renewables Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Mara Renewables Recent Developments
11.8 Cabio
11.8.1 Cabio Corporation Information
11.8.2 Cabio Business Overview
11.8.3 Cabio Microalgae DHA Product Models, Descriptions and Specifications
11.8.4 Cabio Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Cabio Recent Developments
11.9 Solutex
11.9.1 Solutex Corporation Information
11.9.2 Solutex Business Overview
11.9.3 Solutex Microalgae DHA Product Models, Descriptions and Specifications
11.9.4 Solutex Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Solutex Recent Developments
11.10 Kingdomway
11.10.1 Kingdomway Corporation Information
11.10.2 Kingdomway Business Overview
11.10.3 Kingdomway Microalgae DHA Product Models, Descriptions and Specifications
11.10.4 Kingdomway Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Kingdomway Recent Developments
11.11 Fermentalg
11.11.1 Fermentalg Corporation Information
11.11.2 Fermentalg Business Overview
11.11.3 Fermentalg Microalgae DHA Product Models, Descriptions and Specifications
11.11.4 Fermentalg Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Fermentalg Recent Developments
11.12 JC Biotech
11.12.1 JC Biotech Corporation Information
11.12.2 JC Biotech Business Overview
11.12.3 JC Biotech Microalgae DHA Product Models, Descriptions and Specifications
11.12.4 JC Biotech Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 JC Biotech Recent Developments
11.13 Keyuan
11.13.1 Keyuan Corporation Information
11.13.2 Keyuan Business Overview
11.13.3 Keyuan Microalgae DHA Product Models, Descriptions and Specifications
11.13.4 Keyuan Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Keyuan Recent Developments
11.14 Bioplus Life Sciences
11.14.1 Bioplus Life Sciences Corporation Information
11.14.2 Bioplus Life Sciences Business Overview
11.14.3 Bioplus Life Sciences Microalgae DHA Product Models, Descriptions and Specifications
11.14.4 Bioplus Life Sciences Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Bioplus Life Sciences Recent Developments
11.15 Fuxing
11.15.1 Fuxing Corporation Information
11.15.2 Fuxing Business Overview
11.15.3 Fuxing Microalgae DHA Product Models, Descriptions and Specifications
11.15.4 Fuxing Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Fuxing Recent Developments
11.16 ATK Biotech
11.16.1 ATK Biotech Corporation Information
11.16.2 ATK Biotech Business Overview
11.16.3 ATK Biotech Microalgae DHA Product Models, Descriptions and Specifications
11.16.4 ATK Biotech Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 ATK Biotech Recent Developments
11.17 Xinhe Biotech
11.17.1 Xinhe Biotech Corporation Information
11.17.2 Xinhe Biotech Business Overview
11.17.3 Xinhe Biotech Microalgae DHA Product Models, Descriptions and Specifications
11.17.4 Xinhe Biotech Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Xinhe Biotech Recent Developments
11.18 Progress Biotech
11.18.1 Progress Biotech Corporation Information
11.18.2 Progress Biotech Business Overview
11.18.3 Progress Biotech Microalgae DHA Product Models, Descriptions and Specifications
11.18.4 Progress Biotech Microalgae DHA Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Progress Biotech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Microalgae DHA Industry Chain
12.2 Microalgae DHA Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Microalgae DHA Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Microalgae DHA Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Microalgae DHA Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Microalgae DHA Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Microalgae DHA market size was US$ 676 million in 2025 and is forecast to reach a readjusted size of US$ 1608 million by 2032 with a CAGR of 12.7% during the forecast period 2026-2032.
Published Date: 2026-05-31
Pages: 153
USD 4250.00
(Single User License)
The global Microalgae DHA market was valued at US$ 676 million in 2025 and is anticipated to reach US$ 1608 million by 2032, at a CAGR of 12.7% from 2026 to 2032.
Published Date: 2026-05-31
Pages: 133
USD 2900.00
(Single User License)
The global market for Microalgae DHA was estimated to be worth US$ 676 million in 2025 and is projected to reach US$ 1608 million, growing at a CAGR of 12.7% from 2026 to 2032.
Published Date: 2026-05-31
Pages: 155
USD 3950.00
(Single User License)
The global market for Microalgae DHA was estimated to be worth US$ 604 million in 2024 and is forecast to a readjusted size of US$ 1377 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published Date: 2025-10-15
Pages: 133
USD 3950.00
(Single User License)
The global Microalgae DHA market size was US$ 604 million in 2024 and is forecast to a readjusted size of US$ 1377 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 110
USD 4250.00
(Single User License)
The global Microalgae DHA market is projected to grow from US$ 604 million in 2024 to US$ 1377 million by 2031, at a CAGR of 12.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-08
Pages: 179
USD 4900.00
(Single User License)
The global market for Microalgae DHA was valued at US$ 604 million in the year 2024 and is projected to reach a revised size of US$ 1377 million by 2031, growing at a CAGR of 12.7% during the forecast period.
Published Date: 2025-09-08
Pages: 107
USD 2900.00
(Single User License)
The global market for Microalgae DHA was estimated to be worth US$ 615 million in 2024 and is forecast to a readjusted size of US$ 1317 million by 2031 with a CAGR of 11.7% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 124
USD 3950.00
(Single User License)
DHA, Docosahexaenoic acid, with molecular formula C22H32O2, is a primary structural component of the human brain, cerebral cortex, skin, sperm, testicles and retina. DHA can help lowering lipid, lowering blood pressure, anti-inflammatory, enhancing the activity of brain cells, improving eyesight and other effects. DHA is a kind of both Omega-3 essential fatty acids, which is rich in fish oil and microalgae.
Published Date: 2024-04-07
Pages: 117
USD 4900.00
(Single User License)
DHA, Docosahexaenoic acid, with molecular formula C22H32O2, is a primary structural component of the human brain, cerebral cortex, skin, sperm, testicles and retina. DHA can help lowering lipid, lowering blood pressure, anti-inflammatory, enhancing the activity of brain cells, improving eyesight and other effects. DHA is a kind of both Omega-3 essential fatty acids, which is rich in fish oil and microalgae.
Published Date: 2024-01-18
Pages: 141
USD 3950.00
(Single User License)
The global Microalgae DHA market size was US$ 676 million in 2025 and is forecast to reach a readjusted size of US$ 1608 million by 2032 with a CAGR of 12.7% during the forecast period 2026-2032.
Published: 2026-05-31
Pages: 153
The global Microalgae DHA market was valued at US$ 676 million in 2025 and is anticipated to reach US$ 1608 million by 2032, at a CAGR of 12.7% from 2026 to 2032.
Published: 2026-05-31
Pages: 133
The global market for Microalgae DHA was estimated to be worth US$ 676 million in 2025 and is projected to reach US$ 1608 million, growing at a CAGR of 12.7% from 2026 to 2032.
Published: 2026-05-31
Pages: 155
The global market for Microalgae DHA was estimated to be worth US$ 604 million in 2024 and is forecast to a readjusted size of US$ 1377 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published: 2025-10-15
Pages: 133
The global Microalgae DHA market size was US$ 604 million in 2024 and is forecast to a readjusted size of US$ 1377 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 110
The global Microalgae DHA market is projected to grow from US$ 604 million in 2024 to US$ 1377 million by 2031, at a CAGR of 12.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-08
Pages: 179
The global market for Microalgae DHA was valued at US$ 604 million in the year 2024 and is projected to reach a revised size of US$ 1377 million by 2031, growing at a CAGR of 12.7% during the forecast period.
Published: 2025-09-08
Pages: 107
The global market for Microalgae DHA was estimated to be worth US$ 615 million in 2024 and is forecast to a readjusted size of US$ 1317 million by 2031 with a CAGR of 11.7% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 124
DHA, Docosahexaenoic acid, with molecular formula C22H32O2, is a primary structural component of the human brain, cerebral cortex, skin, sperm, testicles and retina. DHA can help lowering lipid, lowering blood pressure, anti-inflammatory, enhancing the activity of brain cells, improving eyesight and other effects. DHA is a kind of both Omega-3 essential fatty acids, which is rich in fish oil and microalgae.
Published: 2024-04-07
Pages: 117
DHA, Docosahexaenoic acid, with molecular formula C22H32O2, is a primary structural component of the human brain, cerebral cortex, skin, sperm, testicles and retina. DHA can help lowering lipid, lowering blood pressure, anti-inflammatory, enhancing the activity of brain cells, improving eyesight and other effects. DHA is a kind of both Omega-3 essential fatty acids, which is rich in fish oil and microalgae.
Published: 2024-01-18
Pages: 141
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now